BioNTech (BNTX) News Headlines

▮ More

Date

Headline

1/20/2021 8:49:35 AM Pfizer & BioNTech Report Encouraging Findings On Vaccine's Effectiveness In Neutralizing U.K. Strain

1/20/2021 8:29:42 AM Pfizer, BioNTech: Vaccine Elicit Antibodies That Neutralize Pseudovirus Bearing SARS-CoV-2 UK Strain

1/8/2021 6:23:29 AM Pfizer, BioNTech Announce Results From In Vitro Study

1/8/2021 5:52:38 AM Pfizer And BioNTech Announce Results From An In Vitro Study

1/1/2021 2:49:04 PM WHO Issues Emergency Use Validation To Pfizer-BioNTech Covid Vaccine

12/29/2020 9:41:42 PM Pfizer, BioNTech To Supply European Union With 100 Mln Addl Doses Of COVID-19 Vaccine

12/23/2020 7:12:34 AM Pfizer & BioNTech Agree With U.S. Government To Supply 100 Mln Additional Doses Of COVID-19 Vaccine

12/23/2020 7:03:27 AM Pfizer And BioNTech Announce Second Agreement To Supply The U.S. With 100 Mln Additional Doses Of COVID-19 Vaccine

12/22/2020 2:49:15 AM NantKwest Stock Goes North, QURE's HOPE-B Trial On Hold, EU Greenlights First COVID-19 Vaccine

12/21/2020 5:07:08 PM European Commission Approves Use Of Pfizer/BioNTech COVID-19 Vaccine

12/21/2020 2:41:27 PM Pfizer And BioNTech Receive Authorization In European Union For COVID-19 Vaccine

12/21/2020 10:02:50 AM Pfizer, BioNTech Receive CHMP Positive Opinion For Their COVID-19 Vaccine

12/21/2020 9:53:34 AM Stock Alert: BioNTech Shares Up On CHMP Positive Opinion For Pfizer-BioNTech COVID-19 Vaccine

12/21/2020 9:24:17 AM Pfizer And BioNTech Get CHMP Positive Opinion For COVID-19 Vaccine

12/18/2020 9:52:41 PM FDA Authorizes Moderna's COVID-19 Vaccine For Emergency Use In U.S.

12/17/2020 9:20:52 PM FDA Panel Recommends Emergency Use Of Moderna's COVID-19 Vaccine

12/16/2020 3:38:14 AM BioNTech, Fosun Pharma In Deal To Supply MRNA-based COVID-19 Vaccine In China

12/16/2020 3:02:53 AM BioNTech, Fosun Pharma To Supply China With MRNA-based COVID-19 Vaccine

12/14/2020 1:28:35 PM Coronavirus Vaccine Rollout In U.S. Has Begun

12/14/2020 6:20:16 AM Pfizer, BioNTech Report Data From German Phase 1/2 Trial With COVID-19 Vaccine Candidate

Biontech (BNTX)